United States of America ex rel. v. ERMI, LLC

CourtDistrict Court, N.D. Georgia
DecidedApril 21, 2022
Docket1:20-cv-04181
StatusUnknown

This text of United States of America ex rel. v. ERMI, LLC (United States of America ex rel. v. ERMI, LLC) is published on Counsel Stack Legal Research, covering District Court, N.D. Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States of America ex rel. v. ERMI, LLC, (N.D. Ga. 2022).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF GEORGIA ATLANTA DIVISION

UNITED STATES OF AMERICA ex

rel. ELIZABETH A. COOLEY,

Plaintiff,

v. CIVIL ACTION FILE NO. 1:20-CV-4181-TWT

ERMI, LLC f/k/a ERMI, INC., et al.,

Defendants.

OPINION AND ORDER This is a False Claims Act action. It is before the Court on the Defendants’ Motion to Dismiss [Doc. 35]. For the reasons set forth below, the Defendants’ Motion to Dismiss is GRANTED in part and DENIED in part. Under Federal Rule of Civil Procedure 15(a)(2), the Court gives the Relator leave to amend the pleading errors in her complaint within 30 days of the date of this Order. I. Background The Court accepts the facts as alleged in the First Amended Complaint as true for purposes of a motion to dismiss. , 941 F.3d 1116, 1122 (11th Cir. 2019). This case arises out of alleged private schemes to defraud federal healthcare and insurance programs. (First Am. Compl. ¶ 1.) Defendant ERMI, LLC manufactures, sells, and leases orthopedic devices that are designed to improve the range of motion in patients’ knees, shoulders, and other joints. ( ¶¶ 1, 43-44.) A Delaware limited liability company since June 2019, ERMI has its headquarters and manufacturing facilities in Fulton County, Georgia, and is owned through a series of related

entities by its chief executive officer, Defendant Thomas P. Branch, M.D. ( ¶¶ 37-38, 42.) ERMI markets its equipment to healthcare professionals as well as patients who are eligible, or potentially eligible, for public healthcare assistance, such as Medicare, workers’ compensation, and military health insurance. ( ¶¶ 51-52.) Of the more than $40 million in revenue that ERMI generates each year, the “overwhelming majority,” according to the First

Amended Complaint, comes from the federal government. ( ¶¶ 83-88.) The Relator Elizabeth Cooley served as ERMI’s chief compliance officer from November 2018 until her termination in October 2019. ( ¶¶ 2, 60-66.) In that role, Cooley’s primary responsibility was to ensure that the company complied with all applicable state and federal regulations and ERMI’s Standards of Conduct. ( ¶ 63.) Based on her review of corporate records and conversations with other ERMI employees, she alleges that ERMI and Branch

carried out five schemes to bill the United States for equipment that was not medically necessary, was priced at above-market rates, or otherwise did not conform to government standards. ( ¶ 1-26.) Those schemes are summarized below. First, ERMI’s research shows that patients regain full range of motion within ten weeks of using its orthopedic equipment, yet it automatically 2 charges for 16-weeks’ use when dealing with the federal government. ( ¶¶ 4-8.) Second, ERMI does not disclose to the Department of Veterans Affairs or the Department of Labor’s Office of Workers’ Compensation Programs that it

offers identical products at steep discounts to customers such as Medicare. ( ¶¶ 9-16.) Third, ERMI has for many years supplied orthopedic devices to patients in Florida (its single largest market in gross revenue and Medicare dollars) either without the required license or with a fraudulently obtained license. ( ¶¶17-21.) Fourth, ERMI routinely provides cash and free equipment to clinicians who agree to prescribe ERMI products to patients

covered by federal healthcare programs, in violation of the Anti-Kickback Statute. ( ¶¶ 22-24.) And fifth, during his medical practice, Branch referred his patients to ERMI despite having a non-exempt financial relationship with the company, in violation of the Stark Law. ( ¶¶ 25-26.) In the course of each scheme, the Relator alleges that ERMI, Branch, and (as to the “Florida-licensure” scheme) End Range of Motion Improvement, Inc. violated the False Claims Act in two ways. (First Am. Compl. ¶¶ 119-27,

163-68, 196, 202, 206, 213-20, 252, 276, 278-84, 305, 308, 316, 318-25, 339-43.) The first way, known as a “presentment claim,” occurs when a person knowingly presents, or causes to be presented, a false claim for payment to the United States. 31 U.S.C. § 3729(a)(1)(A). The second way, known as a “make-or-use claim,” occurs when a person knowingly makes, uses, or causes to be made or used a false record or statement that is material to a claim for 3 payment to the United States. § 3729(a)(1)(B). The Relator also asserts a conspiracy claim under 31 U.S.C. § 3279(a)(1)(C) against all of the Defendants, including Chute 15, Inc., AnthroResearch, LLC, and RoboDiagnostics, LLC.

(First Am. Compl. ¶¶ 347-53.) Her final claim—for retaliation under 31 U.S.C. § 3730(h)—accuses ERMI and Branch of firing her due to her good-faith compliance efforts. ( ¶¶ 354-69.) The Defendants now collectively move to dismiss the First Amended Complaint under Federal Rules of Civil Procedure 8(a), 9(b), and 12(b)(6). II. Legal Standard

A complaint should be dismissed under Rule 12(b)(6) only where it appears that the facts alleged fail to state a “plausible” claim for relief. , 556 U.S. 662, 678 (2009); Fed. R. Civ. P. 12(b)(6). A complaint may survive a motion to dismiss for failure to state a claim, however, even if it is “improbable” that a plaintiff would be able to prove those facts; even if the possibility of recovery is extremely “remote and unlikely.” , 550 U.S. 544, 556 (2007). In ruling on a motion to dismiss, the court

must accept the facts pleaded in the complaint as true and construe them in the light most favorable to the plaintiff. , 711 F.2d 989, 994-95 (11th Cir. 1983); , 40 F.3d 247, 251 (7th Cir. 1994) (noting that at the pleading stage, the plaintiff “receives the benefit of imagination”). Generally, notice pleading is all that is required 4 for a valid complaint. , 753 F.2d 974, 975 (11th Cir. 1985). Under notice pleading, the plaintiff must give the defendant fair notice of his claim and the grounds upon which it rests.

, 551 U.S. 89, 93 (2007) (citing , 550 U.S. at 555). III. Discussion In relevant part, the False Claims Act permits private citizens, acting on behalf of the government, to file a civil action against any person who (A) knowingly presents, or causes to be presented, a false or fraudulent claim for payment or approval; (B) knowingly makes, uses, or causes to be made or used, a false record or statement material to a false or fraudulent claim; [or] (C) conspires to commit a violation of subparagraph (A) [or] (B)[.] 31 U.S.C. § 3729

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Lula T. Beckwith v. Bellsouth Telecommunications
146 F. App'x 368 (Eleventh Circuit, 2005)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
McLean v. Continental Wingate Co.
442 S.E.2d 276 (Court of Appeals of Georgia, 1994)
Joel D. Joseph v. Richard S. Bernstein
612 F. App'x 551 (Eleventh Circuit, 2015)
Richard Ferrell v. Harold E. Wolfe, Jr.
311 F. App'x 253 (Eleventh Circuit, 2009)
Vibe Micro, Inc. v. Igor Shabanets
878 F.3d 1291 (Eleventh Circuit, 2018)
Karun N. Jackson v. Specialized Loan Servicing LLC
898 F.3d 1348 (Eleventh Circuit, 2018)
Carol Wilding v. DNC Services Corporation
941 F.3d 1116 (Eleventh Circuit, 2019)
Benny Barmapov v. Guy Amuial
986 F.3d 1321 (Eleventh Circuit, 2021)
Brooks v. Blue Cross & Blue Shield of Florida, Inc.
116 F.3d 1364 (Eleventh Circuit, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
United States of America ex rel. v. ERMI, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-of-america-ex-rel-v-ermi-llc-gand-2022.